1,236 results on '"Abdollah, F."'
Search Results
2. Real-world data: Call for paradigm shift towards neoadjuvant chemotherapy in patients with upper tract urothelial carcinoma treated with nephroureterectomy - analysis of the ROBUUST registry
3. Testing free PSA percentage as a tool in predicting future risk of developing prostate cancer: A system wide analysis of a contemporary North American cohort
4. Radical cystectomy versus trimodal therapy for non-metastatic muscle-invasive bladder cancer: Analysis of an other-cause mortality matched cohort
5. The impact of radical prostatectomy versus radiation therapy on cancer-specific mortality for patients with localized prostate cancer and positive nodal disease: An analysis of other cause mortality weighted cohort
6. Comparing PSA screening patterns and their role as predictor of prostate cancer incidence and mortality: A system wide analysis of a contemporary North American cohort
7. Active surveillance for prostate cancer in real-world setting: Exploring racial disparities in surveillance intensity and cancer control outcomes
8. Development and validation of a novel nomogram to predict lymph node invasion in upper tract urothelial carcinoma
9. Differential impact of prostate-specific antigen screening pattern on prostate cancer-mortality among non-Hispanic black and non-Hispanic white men: A large, urban health system cohort analysis
10. The role of cytoreductive nephrectomy in metastatic clear cell carcinoma: Analisys of an other-cause mortality matched population from the contemporary immunotherapy era
11. Active surveillance follow-up for prostate cancer: From guidelines to real-world clinical practice
12. Real-world management of high-risk upper tract urothelial carcinoma: Level of adherence to EAU guidelines - analysis of the ROBUUST registry
13. The impact of radical prostatectomy versus radiation therapy on cancer-specific-mortality for non-metastatic prostate cancer: Analysis of an other-cause-mortality matched cohort
14. Association of area of deprivation index with prostate cancer incidence and lethality over a contemporary North American cohort
15. Impact of lymphovascular invasion on survival of surgically treated patients with upper tract urothelial carcinoma: A nationwide analysis
16. Midlife baseline PSA as a predictor of lethal prostate cancer: Racial differences between black and white men
17. Superiority of midlife baseline prostate-specific antigen value over PSA doubling time and velocity in the prediction of lethal prostate cancer development, and mortality: A system wide analysis of a racially diverse North American cohort
18. Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)
19. Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients
20. Did the COVID-19 pandemic accelerate the shift to outpatient surgery in urologic oncology? Results from a state administrative database
21. Frequentist and Bayesian analysis of potential adverse events of the COVID-19 immunization
22. Radical therapy for low-risk upper tract urothelial carcinoma (ROBUUST collaborative group)
23. Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis
24. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer
25. Functional outcomes of clinically high-risk prostate cancer patients treated with robot-assisted radical prostatectomy: a multi-institutional analysis
26. The effect of age at diagnosis on prostate cancer mortality: A grade-for-grade and stage-for-stage analysis
27. The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the “post-dissemination” period
28. Intensity-modulated radiation therapy leads to survival benefit only in patients with high-risk prostate cancer: a population-based study
29. Long-term survival in patients with germ cell testicular cancer: A population-based competing-risks regression analysis
30. Determinants of long-term survival of patients with locally advanced prostate cancer: the role of extensive pelvic lymph node dissection
31. Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk
32. Minimally invasive surgery and its impact on 30‐day postoperative complications, unplanned readmissions and mortality
33. Predicting the risk of lymph node invasion during radical prostatectomy using the European association of urology guideline nomogram: A validation study
34. Propensity-score matched comparison of complications, blood transfusions, length of stay, and in-hospital mortality between open and laparoscopic partial nephrectomy: A national series
35. Impact of annual surgical volume on length of stay in patients undergoing minimally invasive prostatectomy: A population-based study
36. Clinical significance of tumor location for ureteroscopic tumor grading in upper tract urothelial carcinoma
37. The impact of adjuvant chemotherapy on overall survival in patients with node-positive Upper Tract Urothelial Carcinoma (UTUC): Improving precision in medicine with a risk-stratified approach
38. Benefit of lymph node dissection in cn+ patients in the treatment of upper tract urothelial carcinoma: Analysis of ncdb registry
39. External validation of the Bladder Cancer Research Consortium (BCRC) nomogram for predicting survival after radical cystectomy
40. Elevated hemoglobin: Creatinine ratio is a novel preoperative marker for worsened survival outcomes in upper tract urothelial carcinoma: Analysis from the robuust registry
41. Who is shaping the future of urology? A descriptive analysis of current urology residency program directors
42. Evaluation of the utility of lymph-vascular invasion as an independent prognostic predictor of overall survival for patients with renal cell carcinoma that undergo nephrectomy
43. Impact of node count on survival outcomes of lymph node dissection in non-metastatic upper tract urothelial carcinoma: Analysis of the robuust registry
44. Preoperative erectile function is the only predictor of the use of a high number of phosphodiesterase type-5 inhibitors after bilateral nerve-sparing radical prostatectomy
45. Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment
46. Oncological outcomes of patients who achieved surgical quality during minimally invasive radical nephroureterectomy for upper tract urothelial carcinoma: a multicenter retrospective analysis (ROBUUST collaborative group)
47. Surgical quality of robotic vs laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma: a multicenter retrospective analysis (ROBUUST collaborative group)
48. Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy?
49. PT182 - Long-term risk of recurrence in surgically treated renal cell carcinoma: A post-hoc analysis of the Eastern Cooperative Oncology Group - American College of Radiology Imaging Network E2805 Trial cohort
50. In reply to the letter to the editor ‘in Reply to Gandaglia et al.’ by De Bari et al.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.